The global life science tools market size is expected to reach USD 227.3 billion by 2028, expanding at a CAGR of 11.9% over the forecast period, according to a new report by Grand View Research, Inc. Technological advancements in different life science tools are expected to enhance their adoption among prominent end users of the market, thereby leading to the market growth. For instance, improvements in quantitative accuracy, MS resolution, and information sciences have enhanced the accuracy and utility of mass spectrometry-based methods in the field of proteomics.
Products
such as Cell Culture Systems and 3D Cell Culture, Flow Cytometry, PCR and qPCR,
Nucleic Acid Preparation, Nucleic Acid Microarray, and Transfection Devices and
Gene Delivery Technologies have witnessed substantial growth after the COVID-19
pandemic. Novel research has suggested the use of a flow cytometry-based method
for COVID-19 testing. Researchers have also used the technique to explore types
of T cells involved in COVID-19 immune responses.
RT-PCR
assay is the most commonly used method for the detection of viral RNA in
patient samples. Researchers have also developed specific assays to detect
SARS-CoV-2. The Center for Disease Control (CDC) has developed a different test
protocol by validation and comparison of several kits used in the extraction of
nucleic acids. They also used alternative prime and probe sets to detect
SARS-CoV-2 in clinical samples.
For more info visit here: https://www.grandviewresearch.com/industry-analysis/life-science-tools-market
Life Science Tools
Market Report Highlights
- Cell biology
accounted for the largest revenue share in 2020 and is projected to
maintain its dominance throughout the forecast period
- The
proteomics technology segment is expected to expand at the fastest CAGR
throughout the forecast period owing to a rise in demand for precision
medicine
- Researchers
suggest that combined genomics and proteomics data can
potentially be used for neurodegenerative, neuromuscular, and other
chronic disorders; thereby enhancing market growth
- The cell
culture systems and 3D cell culture segment was the largest
revenue-generating product segment in 2020 as cell biology is gaining
importance across multiple aspects of the life science industry
- The cloning
and genome engineering segment is expected to expand at the fastest CAGR
throughout the forecast period
- Gene cloning
has gained significant traction in recent years, becoming a commonly opted
approach to make copies of a gene, a science that otherwise remains
unexplored
- The health
care segment accounted for the largest revenue share in the end-use
segment owing to the utility of life science tools in hospitals, clinics,
diagnostic laboratories, community centers, and physician offices
- Lucrative
opportunities offered by emerging nations has attracted investments from
global firms in the Asia Pacific region, thus driving the region at the
fastest growth rate throughout the forecast period
About Grand View Research
Grand
View Research, Inc. is a U.S. based market research and consulting company,
registered in the State of California and headquartered in San Francisco. The
company provides syndicated research reports, customized research reports, and
consulting services. To help clients make informed business decisions, we offer
market intelligence studies ensuring relevant and fact-based research across a
range of industries, from technology to chemicals, materials and healthcare.
For more info visit @ https://www.grandviewresearch.com
No comments:
Post a Comment